Protect

Stress and anxiety reduction*
Balancing estrogen dominance*
PMS/Hormonal imbalance symptoms*
Brain and memory protective*
Sunburn/sunspots*
Skin firmness & elasticity*
Arthritis*
Tendonitis*
Bursitis*
Wound healing*
Osteoporosis*
Prostate protection*

*These Statements have not been evaluated by the Food and Drug Association, or Health Canada. These products are not meant to diagnose, treat, cure, or prevent any diseases.

Other ingredients: Mixed tocopherols, MCT oil.

*Refrigeration not necessary. Stable for 1 year after opening, 3 years if sealed.

While we are not 'allowed' to provide medical advice, menstruating women have typically used Protect cyclically, taking 6 drops twice a day orally, only between ovulation and menstruation, and not taking it from menstruation until the next ovulation.
For topical treatment of sun damaged skin, burns, acne, or wrinkles, Protect can be applied directly to the affected area.

We are unable to offer medical advice regarding the usage of progesterone, such as inquiries related to pregnancy, menopause or substituting medications. We recommend that these inquiries be directed to your medical provider for proper guidance and assistance.

1. Chishti YZ, Feswick A, Martyniuk CJ. Progesterone increases ex vivo testosterone production and decreases the expression of progestin receptors and steroidogenic enzymes in the fathead minnow (Pimephales promelas) ovary. Gen Comp Endocrinol. 2014 Apr 1;199:16-25. doi: 10.1016/j.ygcen.2014.01.004. Epub 2014 Jan 21. PMID: 24462459.

2. Mohammed H, Russell IA, Stark R, et al. Progesterone receptor modulates ERα action in breast cancer [published correction appears in Nature. 2015 Oct 1;526(7571):144. Serandour, Aurelien A A[Corrected to Serandour, Aurelien A]]. Nature. 2015;523(7560):313-317. doi:10.1038/nature14583

3. Stanczyk FZ. Treatment of postmenopausal women with topical progesterone creams and gels: are they effective? Climacteric. 2014 Dec;17 Suppl 2:8-11. doi: 10.3109/13697137.2014.944496. Epub 2014 Sep 6. PMID: 25196424.

4. Smith SS. Progesterone administration attenuates excitatory amino acid responses of cerebellar Purkinje cells. Neuroscience. 1991;42(2):309-20. doi: 10.1016/0306-4522(91)90377-z. PMID: 1654533.

5. El-Etr M, Rame M, Boucher C, et al. Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions of corpus callosum and cerebral cortex. Glia. 2015;63(1):104-117. doi:10.1002/glia.22736

6. Formby B, Wiley TS. Progesterone inhibits growth and induces apoptosis in breast cancer cells: inverse effects on Bcl-2 and p53. Ann Clin Lab Sci. 1998 Nov-Dec;28(6):360-9. PMID: 9846203.

7. Cowan LD, Gordis L, Tonascia JA, Jones GS. Breast cancer incidence in women with a history of progesterone deficiency. Am J Epidemiol. 1981 Aug;114(2):209-17. doi: 10.1093/oxfordjournals.aje.a113184. PMID: 7304556.

8. MEDICAL TREATMENT OF MALE PATTERN ALOPECIA (ANDROGENIC ALOPECIA)

9. Correction of hormonal imbalance in patients with diffuse forms of mastopathy – the basis of pathogenetic therapy and oncoprophylaxis

10. Brkic, M. , Vujovic, S. , Ivanisevic, M. , Ivovic, M. , Gajic, M. , Marina, L. , Barac, M. , Barac, B. , Djogo, A. , Malesevic, G. and Franic, D. (2016) The Influence of Progesterone Gel Therapy in the Treatment of Fibrocystic Breast Disease. Open Journal of Obstetrics and Gynecology, 6, 334-341. doi: 10.4236/ojog.2016.65042.

11. Topical progesterone cream has an antiproliferative effect on estrogen-stimulated endometrium.

12. POSTHUMUS RG. [The use and the possibilities of progesterone in the treatment of glaucoma]. Ophthalmologica. 1952 Jul;124(1):17-25. Undetermined Language. doi: 10.1159/000301245. PMID: 12983046.